Sponsor: ECOG-ACRIN Cancer Research Group
Sponsor Study ID: EA8134
Study Title: InPACT International Penile Advanced Cancer Trial (International Rare Cancers Initiative study)
CTO #: 103220
NCT Number: NCT02305654
Phase: III
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Other Male Genital
Study Objectives: This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a series of questions that routinely arise in the sequencing of treatment. The study design has evolved from lengthy international consultation that has enabled us to build consensus over which questions arise from current knowledge and practice. It will enable potential randomisation for the majority of patients with inguinal lymph node metastases and will provide data to inform future clinical decisions.